|
|
DAVID J.
Fink, Ph.D. Dr. David Fink’s career in biotechnology and biomedical product development spans over 30 years as a researcher, consultant, entrepreneur and officer of several start-up biotech companies. At Battelle’s Columbus Labs, he managed more than 100 research projects over a 12-year period. He founded CollaTek Inc., a collagen biomaterials company, in 1986. He has also served as VP of International Technology Development for Osiris Therapeutics, an adult stem cell company, and as President and COO of Chondros Inc., another cell therapy company. He is currently a Founder and VP for R&D of Cell Targeting, LLC, a cell therapy start-up in Cleveland, OH. At techcenter@UMBC, Dr. Fink coordinates incubator services and advises early-stage incubator companies. For the past 3 years, he has also been an instructor for UMBC’s ACTiVATE entrepreneurship program for women. He received his BSChE from the University of Cincinnati and his PhD in Chemical Engineering from the University of Michigan. He has authored over 40 scientific papers and book chapters, and he been awarded 22 US patents.
|
